UROLOGY, vol.85, no.3, 2015 (SCI-Expanded)
OBJECTIVE To evaluate programmed death ligand 1 (PD-L1) expression in urothelial carcinoma of the bladder in relationship with tumor-infiltrating CD8+ T cells.